The Valley Desk

NCT02906397 · Interventional trial

Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)

Overall registry status Completed

Phase 1

Conditions ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov